Article
The Duchenne Lottery: Why Where a Child Lives May Now Matter More Than Ever
ELEVIDYS, the first Duchenne gene therapy, is approved in the US and Japan but rejected in Europe, leaving a child's access increasingly shaped by geography.
Tag
#global
All articles and blog posts tagged #global.
Articles
Blog
Blog
DMD Treatment Access by Country: Why It Varies
Dmd treatment access by country varies through regulators, payers, health technology assessment, pricing, and local budgets.
Blog
Crossing Borders for Duchenne Treatment
Some families relocate or travel abroad for Duchenne treatment. The decision involves access, evidence, logistics, finances, and family.